• Je něco špatně v tomto záznamu ?

Covalent binding of cisplatin impairs the function of Na(+)/K(+)-ATPase by binding to its cytoplasmic part

M. Huličiak, J. Vacek, M. Sebela, E. Orolinová, J. Znaleziona, M. Havlíková, M. Kubala,

. 2012 ; 83 (11) : 1507-13. [pub] 20120227

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12023995

This study was aimed at verifying the hypothesis that acute kidney failure accompanying cisplatin administration in the cancer therapy could be due to cisplatin interaction with the cytoplasmic part of Na(+)/K(+)-ATPase. Our results demonstrated that cisplatin-binding caused inhibition of Na(+)/K(+)-ATPase, in contrast to other platinated chemotherapeutics such as carboplatin and oxaliplatin, which are known to be much less nephrotoxic. To acquire more detailed structural information, we performed a series of experiments with the isolated large cytoplasmic segment connecting transmembrane helices 4 and 5 (C45 loop) of Na(+)/K(+)-ATPase. Electrochemistry showed that cisplatin is bound to the cysteine residues of the C45 loop, mass spectrometry revealed a modification of the C45 peptide fragment GSHMASLEAVETLGSTSTICSDK, which contains the conserved phosphorylated residue Asp369. Hence, we hypothesize that binding of cisplatin to Cys367 can cause sterical obstruction during the phosphorylation or dephosphorylation step of the Na(+)/K(+)-ATPase catalytic cycle.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12023995
003      
CZ-PrNML
005      
20121206114239.0
007      
ta
008      
120815e20120227enk f 000 0#eng||
009      
AR
024    7_
$a 10.1016/j.bcp.2012.02.015 $2 doi
035    __
$a (PubMed)22394404
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Huličiak, Miroslav $u Department of Biophysics, Palacký University in Olomouc, Olomouc, Czech Republic.
245    10
$a Covalent binding of cisplatin impairs the function of Na(+)/K(+)-ATPase by binding to its cytoplasmic part / $c M. Huličiak, J. Vacek, M. Sebela, E. Orolinová, J. Znaleziona, M. Havlíková, M. Kubala,
520    9_
$a This study was aimed at verifying the hypothesis that acute kidney failure accompanying cisplatin administration in the cancer therapy could be due to cisplatin interaction with the cytoplasmic part of Na(+)/K(+)-ATPase. Our results demonstrated that cisplatin-binding caused inhibition of Na(+)/K(+)-ATPase, in contrast to other platinated chemotherapeutics such as carboplatin and oxaliplatin, which are known to be much less nephrotoxic. To acquire more detailed structural information, we performed a series of experiments with the isolated large cytoplasmic segment connecting transmembrane helices 4 and 5 (C45 loop) of Na(+)/K(+)-ATPase. Electrochemistry showed that cisplatin is bound to the cysteine residues of the C45 loop, mass spectrometry revealed a modification of the C45 peptide fragment GSHMASLEAVETLGSTSTICSDK, which contains the conserved phosphorylated residue Asp369. Hence, we hypothesize that binding of cisplatin to Cys367 can cause sterical obstruction during the phosphorylation or dephosphorylation step of the Na(+)/K(+)-ATPase catalytic cycle.
650    _2
$a zvířata $7 D000818
650    _2
$a protinádorové látky $x metabolismus $x farmakologie $7 D000970
650    _2
$a mozková kůra $x enzymologie $7 D002540
650    _2
$a cisplatina $x metabolismus $x farmakologie $7 D002945
650    _2
$a molekulární modely $7 D008958
650    _2
$a vazba proteinů $7 D011485
650    _2
$a konformace proteinů $7 D011487
650    _2
$a sodíko-draslíková ATPasa $x antagonisté a inhibitory $x metabolismus $7 D000254
650    _2
$a spektrometrie hmotnostní - ionizace laserem za účasti matrice $7 D019032
650    _2
$a prasata $7 D013552
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vacek, Jan
700    1_
$a Sebela, Marek
700    1_
$a Orolinová, Eva
700    1_
$a Znaleziona, Joanna
700    1_
$a Havlíková, Marika
700    1_
$a Kubala, Martin
773    0_
$w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 83, č. 11 (20120227), s. 1507-13
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22394404 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120815 $b ABA008
991    __
$a 20121206114312 $b ABA008
999    __
$a ok $b bmc $g 946143 $s 781323
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2012 $b 83 $c 11 $d 1507-13 $e 20120227 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
LZP    __
$a Pubmed-20120815/12/02

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...